“Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?”, Swiss Med Wkly, vol. 140, no. 3536, p. w13050, Aug. 2010, doi: 10.4414/smw.2010.13050.